Process for detection of alzheimer's disease from a serum sample
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 5, 2017
Issued Date -
N/A
app pub date -
Jul 16, 2012
filing date -
Jul 14, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed is a method of detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI). Also disclosed is a process for detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI) comprising (a) detecting a first concentration of lipocalin-PDS/TTR complex in a blood sample or urine sample from the subject, (b) determining a second concentration of PDS/TTR complex in a blood sample or urine sample from an unaffected individual, and (c) comparing the first and second concentrations, wherein a lower first concentration as compared to the second concentration is indicative of the subject having or being at risk of developing Alzheimer's disease.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2012 Application Filing Year
- G01N Class
- 8064 Applications Filed
- 6361 Patents Issued To-Date
- 78.89 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- G01N Class
- 0 % this patent is cited more than
- 8 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jun 5, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 5, 2029 |
